Home/Pipeline/Peripheral nerve pain agent

Peripheral nerve pain agent

Neuropathic pain

PreclinicalActive

Key Facts

Indication

Neuropathic pain

Phase

Preclinical

Status

Active

Company

Australian‑listed biotech advancing TRPC‑channel inhibitors for cardiovascular and neurological unmet needs.

Drug	Company	Phase	Status
NTRX-07	NeuroTherapia	Pre-clinical	Active
Neuropathic Pain Model Service	NeuroProof	Pre-clinical	Active
Sana Device for Neuropathic Pain	Sana Health	Pivotal Trial Completed	Active
Neuropathic Pain Program	VersaPeutics	Preclinical	Active
Cerebro Platform for Pain	Vonova.io	Pre-clinical	Active
LAT9997	Lateral Pharma	Phase 2 (next-gen)	Active; composition-of-matter patent secured
ZYNPN	Zyneyro	Pre-clinical	Active
XT-150 (Preclinical)	Xalud Therapeutics	Preclinical	Active
ONO-2910	Ono Pharmaceutical	Phase 2	Active
VX-548	Vertex Pharmaceuticals	Phase 2	Active
BDT272	KYORIN Pharmaceutical	Preclinical	Active (In-licensed)
HSK16149	Haisco Pharmaceutical Group	Phase III	Active